Abstract Background: Epigenetic and genetic alterations synergistically drive cancer initiation and progression, yet one blood draw rarely yields enough cell-free DNA (cfDNA) to profile both modalities. Current co-detection strategies either demand high tumor burden or custom chemistry and cannot be retro-applied to existing datasets. We present MMcall, a computational tool that reconstructs the original four-base genome from conventional bisulfite-sequencing reads and simultaneously detects mutations and methylation variants without new benchwork, delivering fully integrated genomic/epigenomic signatures from one single library. Methods: MMcall reconstructs the original four-base genome from standard bisulfite-converted reads by jointly modeling complementary top- and bottom-strand base counts. Because the G nucleotide on the strand opposing a C is unaffected by bisulfite conversion, the strand-specificity principle is used to restore pre-conversion sequence. A machine-learning error-suppression module is then applied to suppress the high technical noise inherent to bisulfite treatment. The algorithm simultaneously outputs methylation-variant allele frequency (MVAF) and somatic-variant allele frequency (SVAF) from the same library, enabling epigenetic and genetic profiling without additional wet-lab steps. Results: Benchmarked against 0 -1% tumor-fraction serial dilutions of Seraseq® ctDNA Reference Material and an in-house standard (OverC Monitor panel; 1000X methylation depth, 20000X mutation depth), MMcall demonstrated near-perfect concordance with expected methylation levels (R20.99) and detected mutations down to 0.25%. At 0.5-1% VAF, SVAF measurements by MMcall closely matched those obtained by ultra-deep sequencing (HS-UMI, 35000X), yielding 99.7% NPA (95% CI: 99.3-99.9%) and 86.9 % PPA (95 % CI: 77.8-93.3%). No false-positive calls were observed across predefined hotspot loci in any negative control, confirming robust suppression of technical noise. Conclusion: MMcall jointly calls mutations and methylation variants at single-base resolution without additional bench steps. The method offers a cost-effective route to richer molecular information for early cancer detection and minimal residual disease monitoring. Citation Format: Xingyu Yang, Jing Su, Chen Yang, Xiaoling Li, Si Zhang, Xianrong Chen, Bingsi Li. Integrated, base-resolution profiling of genetic and epigenetic signatures in cell-free DNA abstract. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 111.
Building similarity graph...
Analyzing shared references across papers
Loading...
X. Yang
J. Su
C. Yang
Cancer Research
Burning Rock Biotech (China)
Building similarity graph...
Analyzing shared references across papers
Loading...
Yang et al. (Fri,) studied this question.
www.synapsesocial.com/papers/69d1fc70a79560c99a0a201e — DOI: https://doi.org/10.1158/1538-7445.am2026-111